Overview

Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects

Status:
Completed
Trial end date:
2019-01-27
Target enrollment:
Participant gender:
Summary
A Non-Randomized, Open-Label, Three-Part, Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Rifampin, and Quinidine on the Pharmacokinetics and Safety of EDP-938 in Healthy Subjects
Phase:
Phase 1
Details
Lead Sponsor:
Enanta Pharmaceuticals
Collaborator:
Pharmaceutical Research Associates
Treatments:
Hydroxyitraconazole
Itraconazole
Quinidine
Quinidine gluconate
Rifampin